Daily news email for February 10, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
Vectron Biosolutions Obtains Strong Results for Biosimilar Production

Sistemic to Work with TiGenix On Landmark EUR 5. ...

Xceleron Announces New Investment and Move to Purpose-Built Laboratories in U.S.

IDEA Bio-Medical Sells HTS/HCS Cell Imaging System to The Medical University of South Carolina

Biotage Introduces Biotage® SNAP Ultra High Performance Flash Chromatography Cartridges

BioSpace
Silence Therapeutics plc Announces Board Changes and Appointment of New Chief Executive Officer

New Target for Alzheimer's Drugs, University of California, Riverside Study

Ex-Takeda Pharmaceutical Co. Ltd. Exec Committed Insider Trading, Claims

Obesity is Associated With Altered Brain Function, University of Turku Study

DNA Sequencing Helps Identify Cancer Cells for Immune System Attack, Washington University School of Medicine Study

BioSpace - Breaking News
Lupus Foundation of America Seeks Research Applications to Advance Science and Medicine of Lupus

Exelixis, Inc. Announces Pricing of $60.5 Million Public Offering of Common Stock

Zalicus Inc. and Hydra Collaborate to Advance Novel Ion Channel Product Candidates for the Treatment of Pain

Osiris Therapeutics, Inc. Provides Update Regarding the Genzyme Corporation/Sanofi Pasteur Relationship

Another Strong Year for Shire plc With Revenues Exceeding $4 Billion for the First Time and Non GAAP EPS up 26% to $5.34

Biotech News - Business Wire
Research and Markets: Biomedical Materials Subscription - Reports on New and Existing Application Areas

CardioNet, Inc. Acquires ECG Scanning & Medical Services, Inc.

Arrowhead Reports Fiscal 2012 First Quarter Financial Results

Ligand to Present at the BIO CEO and Investor Conference on February 13

ArQule, Inc. to Present at Leerink Swann 2012 Global Healthcare Conference

Biotech News - PR Newswire
Spherix to Present at the LHA Life Sciences & Medical Technologies Virtual Conference on February 16

Insmed Incorporated Provides Update on Clinical Program for ARIKACE®

Neuland Labs Reports Third Quarter Fiscal Year 2012 Financial Results

Pharma IQ Publishes Big Pharma Global Recession Report - 44.4% Fear Redundancy in 2012

Soligenix Announces Results From Its Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
Americans Warming to Healthcare Reform Law

E-Prescriptions Could Improve Patient Adherence

Drug Supplies and Economics 101

Big Pharma Declares War on Neglected Diseases

Two Life Sciences IPOs Debut Below Target

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
OptiNose Announces First Patient Enrolled in Phase III Study of Sumatriptan Powder Delivered Intranasally with Innovative Bi-directional Device

bluebird bio to Present at the Leerink Swann 2012 Global Healthcare Conference

BioReference Announces 2012 Annual Meeting Date

Research and Markets: Depression Global Clinical Trials Review, H1, 2012 Report Provides Briefing Pertaining To the Number of Trials for the Key Drugs for Treating Depression

Velomedix Closes New Financing, Strengthens Leadership Team

Clinical Trials - PR Newswire
USANA® Probiotic Receives ConsumerLab.com Certification

First Prospective Clinical Trial of Adaptive Radiotherapy for Head & Neck Cancer Patients

University Teams Tap Mobile Phones and Social Networks to Fight Non-communicable Diseases

New Clinical Results Further Distance the BIRMINGHAM HIP Resurfacing System From Failed Metal-on-Metal Hip Implants

Elsevier Launches TargetInsights, Streamlining Target Discovery and Validation Workflow

CNN Top Stories
120 ships trapped in Europe's icy waters

Obama to compromise on birth control

Blasts hit Syrian government buildings

Ex-addicts find healthy new 'high'

Compromise likely on contraceptives

Contract Pharma
Particle Sciences, CHEMO in Hormone Development Pact

Bosch To Acquire Eisai\'s Machinery Business

PPD, Scottish Government In Clinical Alliance

Vince and Associates Gains USP Certification

Clinipace Appoints CMO of European Ops

FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Nuevo factor de riesgo para la leucoencefalopatía multifocal progresiva (PML por sus siglas en inglés) relacionado con Tysabri (natalizumab)

FDA Drug Safety Communication: Important drug interactions between Victrelis (boceprevir) and ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitor drugs

FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs)

Prescription to Over-the-Counter (OTC) Switch List

Resources and Tools for Preventing Surgical Fires

FDA News - Business Wire
FDA's Oncologic Drugs Advisory Committee (ODAC) Votes to not Support Benefit/Risk Profile of DACOGEN® (decitabine) in Acute Myeloid Leukemia

Impax Laboratories Provides Update on Status of Warning Letter Resolution for its Hayward Facility

BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review for Phase III Program

Ironwood Announces FDA Advisory Committee Meeting Will Not Be Scheduled in Connection with New Drug Application for Linaclotide

RelayHealth and McKesson Specialty Health Administer First Class-Wide Transmucosal Immediate Release Fentanyl REMS Program

FDA Press Releases
FDA investigating illegal online sale of handheld dental X-ray units

FDA issues draft guidance on biosimilar product development

FDA and industry reach agreement in principle on medical device user fees

FDA approves Gleevec for expanded use in patients with rare gastrointestinal cancer

FDA takes action against New York cheese manufacturer

FDA Vaccines, Blood and Biologics - What's New
Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

Cord Blood Banking ââ¬â Information for Consumers

Influenza Virus Vaccine for the 2011 - 2012 Season

Fluzone, Fluzone High-Dose and Fluzone Intradermal

FierceBiotech
NeurogesX slammed again as FDA panel spurns pain patch

Eisai loses panel vote on new Dacogen use

Mouse study triggers demands for a possible Alzheimer's treatment

FDA maps out long-awaited rules for the biosimilars business

High price of failure drives drug development costs into the stratosphere

FierceBiotech IT
EMC to found Russian cloud computing, 'Big Data' hub

Eagle Genomics, Cycle Computing win bid to develop bioinformatics solutions

Norway's sequencing project will need major IT infrastructure

Oracle announces new round of projects in IT, clinical trials

Supercomputing supports genetic, cancer research in Arizona

FierceBiotech Research
Umbilical cord stem cells may restore infants' hearing

Obama seeks $156M to boost Alzheimer's research through 2013

Can't get enough donuts A specific gene variation may explain why

Time for a walnut, grape seed, fruit, vegetable and fish oil sandwich

CA stem cell researchers planning for life without state funding

FiercePharma
Merck says Victrelis can interfere with HIV meds

LEO Pharma slapped with sales-rep overtime suit

Novartis CEO calls external focus key to fast-changing pharma

FDA panel nixes new use for Amgen's Xgeva

Watson chief has big brand plans for $6B war chest

FiercePharma Manufacturing
Projects in India, Belgium expand OmniChem's API capacities

Another generic settlement: Janssen, Watson agree on birth control pill

ViroPharma responding quickly to FDA delay of Cinryze manufacturing expansion

Decision on new GSK plant location to come soon

Ernst & Young nailed for $2 million for accounting on Medicis

FierceVaccines
Novartis' Bexsero successfully protects vast majority of infants

Hints of a heroin vaccine from Mexico

Bacterial cancer vaccines show glimpses of activity

Researchers target vaccines for the First Nation

Merck's RotaTeq not linked with bowel problems

Health News - BizJournals.com
Biotech Onyx on the rise

Six facilities to establish Level II psychiatric care for children

U-M licenses cyanide antidote to California startup

Austin supplement maker boosting brains and bodies

Florida Senate approves new restrictions on medical malpractice lawsuits

Health News - CNBC
LabCorp 4Q profit up 3 pct; revenue, expenses rise

Obama to speak on contraceptive policy: White House

Halozyme to sell 6.8 million shares

FDA issues plan to avoid heparin contamination

Generics drugs help PharMerica to bigger 4Q profit

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
With Progress on Debt Accord, Greece Scrambles to Cut Pharma Costs

FDA Issues Draft Guidance for Getting Biosimilars Approved

Cytomedix Picks Up Stem Cell Therapy Firm Aldagen

U.S. Drug Manufacturing Decline Reflects Wage Gap and Regulatory Scrutiny

Sistemic Joins 5.9M TiGenix-Led EU Consortium to Develop Stem Cell Rheumatoid Arthritis Therapy

Marketwire - Pharma and Biotech
LifeSci Advisors Publishes Second ADCETRIS Survey Results

CardioComm Solutions Launches Series of Marketing and Public Relations Initiatives in Support of Move into Consumer Medical Market

Immunovaccine Announces a Non-Brokered Private Placement of up to $3 Million

Skystar Sets Record Date and Meeting Date for 2011 Annual General Meeting

Society of Critical Care Medicine Conference in Houston Has 3 Research Studies Presented Involving the Daxor BVA-100 Blood Volume Analyzer

MassBio News
STEM Update from the White House: Engage to Excel: Producing One Million Additional College Graduates with STEM Degrees

MassBio Leading Edge Award Nominations due February 24th

Four New Entrepreneurs Selected for MassCONNECT Mentoring

NUCLEA BIOTECHNOLOGIES ANNOUNCES $3.4 MILLION IN CAPITAL COMMITMENTS

Annual Policy Breakfast Makes Headlines on Healthcare Reform

Medical Pharma - PR Newswire
4.5 Million Americans Living with Total Knee Replacement

LCA-Vision to Present at the LHA Life Sciences & Medical Technologies Virtual Conference

Jury Awards $15 Million to Breast Cancer Victim Against Doctor for Misdiagnosis and Negligent Care

avVenta Cycles for Survival

Large Orthopedic Practice Receives Viztek's Complete Orthopedic DR+PACS Bundle

National Center for Biotechnology Information
GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

SRA News

Nature Biotechnology
OpenVigilfree eyeballs on AERS pharmacovigilance data

The blinded buyer

Planning for the exit

PRIDE Inspector: a tool to visualize and validate MS proteomics data

2011Big biotechs gorge on debt

New York Times- Biotechnology
Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge

Drew Endy: Better Computing for the Things We Care About Most

New York Times- Pharmaceuticals
Killer Meds, Warring Feds

Exemestane, Thought to Prevent Cancer, Also Causes Bone Loss

Children’s A.D.D. Drugs Don’t Work Long-Term

Army Studies Workout Supplements After 2 Deaths

Pfizer and Eli Lilly, Squeezed by Generics, Top Forecasts

OnBioVC
Functional Neuromodulation, Inc.: Series A $10.4M

Uptake Medical, Inc.: Series C $35M

Topica Pharmaceuticals, Inc.: Series B $27M

GenoLogics, Inc.: Series D $8M

Courtagen Life Sciences, Inc.: Series B $8M

Outsourcing-Pharma
An experienced CMO is key to successful biologics development says Cobra Biologics

Parexel discusses transdermal drug delivery techs

Sponsors and CROs differ on perception of service quality, says the Avoca Group

Recipharm CEO talks CMO sector recovery and Asian plans

Covance adding mass spec for biosimilars

Pharma News - Business Wire
XenoPort to Present at the Leerink Swann Global Healthcare Conference

Walgreens Makes Shopping Easier with Additional Online Savings and New Weekly Ad Circular

Company Profile for Clovis Oncology

Alexion to Present at the Leerink Swann 2012 Global Healthcare Conference

Epizyme to Participate in Three Upcoming Conferences

Pharma News - PharmiWeb
Laboratory Corporation of America® Holdings Announces 2011 Fourth Quarter and Full Year Results

Strategic Drug Development and Consulting Practices Provide Knowledge-Based Approach

GSK joins new global partnership to help defeat ten neglected tropical diseases by 2020

Lundbeck strengthens its European organization

Boehringer Ingelheim launches 'Lean-to-Clinic' program for fast drug product supply

Pharma News - PR Newswire
UBM Medica's ONCOLOGY to Feature Special Content on Role of Genetic Testing in GI Cancers

Zacks' Voice of the People highlights opportunities with Walgreen, Occidental Petroleum and Brown & Brown

Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.

Anthera Announces Fourth Quarter 2011 Financial Report and Conference Call

CHEMO and Particle Sciences Partner to Provide the Only Development to Commercialization Solution for Hormone Eluting Drug/Device Combination Products

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute

PRWeb - Biotechnology
Noble Biomaterials Raises $8 million in Series B Equity Financing

PetroAlgae Changes Name to Parabel

Infinata's BioPharm Clinical Incorporates Massive New Data Sets to...

Third Annual Bay Area Biomedical Device Conference March 28th 2012 @...

Permanent and Indestructible Embedded Printing For Medical Parts Made...

PRWeb - Pharmaceuticals
Baltimore Drug Injury Lawyer Named To Maryland Top 100 List by Super...

Groundbreaking Medication in Men's Sexual Health to Revolutionize...

Acupuncture for Children San Francisco Chinese Medicine College Now...

Abbott Reports $1.5 Billion of Litigation Reserves Related to Ongoing...

The Consumer Justice Foundation Alerts the Public to the Filing of an...

Scientific American
Nuclear Reactor Approved in U.S. for First Time Since 1978

Alzheimer's Disease Symptoms Reversed in Mice

Widespread Plasticizer Clouds Doping Tests of Cyclists

Success Is Official: Russian Team Breaches Buried Antarctic Lake

Sight Seen: Gene Therapy Restores Vision in Both Eyes

Sports - ESPN Basketball
Weekend Watch: Feb. 10-12

Zags end 12-game streak of rival Saint Mary's

Zeller helps No. 23 Indiana charge past Illinois

Taylor, Wisconsin edge Minnesota in overtime

Tenn. St. halts Murray State's unbeaten run

Sports News - ESPN
Not guilty plea entered for LSU QB Jefferson

Former USC QB Mustain signs with White Sox

Neighbors: Sandusky watched kids from deck

Ohio St. trustees OK rules compliance office

Former LSU QB Jefferson enters not guilty plea

Xconomy Life Sciences
SD Life Sciences Roundup: Illumina, Applied Proteomics, & Tocagen

Persistence Pays Off for Synchroneuron Founder

Persistence Pays Off for Synchroneuron Founder With $6M Series A

Celgene Pours $15M Into Acetylon, Takes Observer Role on Board

Celgene Pours $15M Into Acetylon, Takes Observer Role on Board

Yahoo Biotech News
Two Genes for Sealing In Memories Identified (LiveScience.com)

Origin expects to grow China's first GMO corn in 2013 (Reuters)

FDA sets draft rules for biotech drug copies (Reuters)

4 New Genes Linked to Type 2 Diabetes (HealthDay)

More Success With Gene Therapy for Blindness (HealthDay)